- Report
- October 2024
- 193 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- June 2024
- 200 Pages
Global
From €7601EUR$7,950USD£6,363GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
Saudi Arabia
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
India
From €1434EUR$1,500USD£1,200GBP
- Report
- May 2022
- 56 Pages
Global
From €1912EUR$2,000USD£1,601GBP
- Report
- December 2021
- 80 Pages
Africa
From €1912EUR$2,000USD£1,601GBP
- Report
- December 2021
- 40 Pages
Vietnam
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
United States
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
South Korea
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
Russia
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
Japan
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
Ireland
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
Germany
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
France
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
China
From €1434EUR$1,500USD£1,200GBP
- Report
- December 2021
- 40 Pages
Brazil
From €1434EUR$1,500USD£1,200GBP

The Intra Abdominal Infection Drug market is a subset of the Infectious Diseases Drugs market. Intra Abdominal Infection Drugs are used to treat infections of the abdominal cavity, such as appendicitis, diverticulitis, and peritonitis. These drugs are typically antibiotics, such as cephalosporins, fluoroquinolones, and carbapenems. They are used to treat bacterial infections, and may also be used to treat fungal and viral infections. Intra Abdominal Infection Drugs are typically administered orally or intravenously.
The Intra Abdominal Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, Novartis, Johnson & Johnson, and Bayer. Show Less Read more